Literature DB >> 25857280

The role of depressive symptomatology in peri- and post-menopause.

Erika Borkoles1, Nick Reynolds2, David R Thompson3, Chantal F Ski4, Lily Stojanovska5, Remco C J Polman6.   

Abstract

OBJECTIVES: There is evidence that menopausal symptoms manifested at peri-menopause occur less frequently when compared to the symptoms experienced at post-menopause. The aim of this study was to investigate this and to test the hypothesis that depressive symptomatology mediates the relationship between menopausal stage and symptom frequency.
METHODS: This cross-sectional study included 213 women (M age=52 years), of whom 125 were peri- and 88 post-menopausal. Measures comprised the Center for Epidemiologic Studies-Depression scale (CES-D) and the Women's Health Questionnaire (WHQ) vasomotor symptoms and somatic symptoms subscales.
RESULTS: Multiple mediated regression analyses provided evidence that somatic symptoms and vasomotor symptoms were less frequent at post- compared to peri-menopause, and that these differences were mediated by depressive symptomatology. Multivariate effect sizes ranged from small to moderate, and univariate effect sizes were uniformly small with wide confidence intervals.
CONCLUSIONS: The frequency of vasomotor and somatic symptoms appears to increase with depressed affect. The management of symptoms could include interventions of a psychotherapeutic nature, which may offset this effect, particularly in women for whom depressive symptoms are a feature of the climacteric syndrome. The extent to which depression and the climacteric syndrome may be causally related to one another remains unclear and longitudinal research should further examine the mechanisms of this association.
Copyright © 2015 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Depression; Menopause; Somatic symptoms; Vasomotor symptoms

Mesh:

Year:  2015        PMID: 25857280     DOI: 10.1016/j.maturitas.2015.03.007

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  3 in total

1.  Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study.

Authors:  Camilla Callegari; Marta Ielmini; Ivano Caselli; Giulia Lucca; Celeste Isella; Marcello Diurni; Fabiana Pettenon; Nicola Poloni
Journal:  Psychopharmacol Bull       Date:  2019-02-15

2.  Association of the Dietary Inflammatory Index with Depressive Symptoms among Pre- and Post-Menopausal Women: Findings from the National Health and Nutrition Examination Survey (NHANES) 2005-2010.

Authors:  Deniz Azarmanesh; Elizabeth R Bertone-Johnson; Jessica Pearlman; Zhenhua Liu; Elena T Carbone
Journal:  Nutrients       Date:  2022-05-09       Impact factor: 6.706

3.  Risk of Psychiatric Disorders Following Symptomatic Menopausal Transition: A Nationwide Population-Based Retrospective Cohort Study.

Authors:  Li-Yu Hu; Cheng-Che Shen; Jeng-Hsiu Hung; Pan-Ming Chen; Chun-Hsien Wen; Yung-Yen Chiang; Ti Lu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.